R. Santhanakrishnan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
R. Santhanakrishnan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Karikalan Nagarajan
Indian Council of Medical Research- National Institute for Research in Tuberculosis Department of Social & Behavioural Research Chen nai 600031
2 shared publications - A. Mathur
Ministry of Health and Family Welfare
1 shared publication Adhin Bhaskar
Indian Council of Medical Research- National Institute for Research in Tuberculosis Department of Statistics Chennai 600031
1 shared publication- Aishwarya Venkataraman
ICMR - National Institute for Research in Tuberculosis, Chennai, India
1 shared publication Anil Singarajipura
State TB Office, National Tuberculosis Elimination Programme, Bangalore , Karnataka 560001
1 shared publication- Ariarathinam Newtonraj
Department of Community Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India
1 shared publication
Latest Publications
- Open Access
- 18 March 2026
- Published by Oxford University Press (OUP) in International Health
- Vol. 18 (6) , 801-809
Implementation challenges of 3-month once-weekly rifapentine and isoniazid TB-preventive treatment in India
Background: Implementing three months of once-weekly rifapentine and isoniazid (3HP) for tuberculosis preventive therapy among household contacts (HHCs) of bacteriologically confirmed pulmonary TB patients in India presents programmatic challenges requiring understanding from beneficiary and provider perspectives. Methods: From May 2023 to March 2024, nine focus group discussions were conducted across five rural and urban program settings: three with HHCs who received 3HP (n=28) and six with frontline healthcare providers (n=69) delivering the regimen within a multicentric implementation study. Descriptive thematic analysis explored experiences, perceptions, and implementation challenges. Results: Analysis of FGDs yielded four major themes: (i) perceptions and acceptance of 3HP; (ii) barriers to 3HP; (iii) advocacy and communication and social mobilization; and (iv) suggestions for improving 3HP. Participants appreciated the short, once-weekly regimen and family encouragement supporting adherence. However, reluctance to undergo testing without symptoms, fear of side effects, stigma, and access barriers limited uptake. Suggested solutions included transport support, mobile X-ray services, reminder tools, and family DOTS providers. Providers highlighted workforce shortages and the need for additional staff. Conclusion: Both groups emphasized tailored counselling, strengthened community awareness, and media advocacy to improve uptake, adherence, and program sustainability of 3HP implementation at scale nationwide.
- 18 March 2026
- Published by Oxford University Press (OUP) in International Health
- Vol. 18 (6) , 801-809
Open AccessImplementation challenges of 3-month once-weekly rifapentine and isoniazid TB-preventive treatment in India
Background: Implementing three months of once-weekly rifapentine and isoniazid (3HP) for tuberculosis preventive therapy among household contacts (HHCs) of bacteriologically confirmed pulmonary TB patients in India presents programmatic challenges requiring understanding from beneficiary and provider perspectives. Methods: From May 2023 to March 2024, nine focus group discussions were conducted across five rural and urban program settings: three with HHCs who received 3HP (n=28) and six with frontline healthcare providers (n=69) delivering the regimen within a multicentric implementation study. Descriptive thematic analysis explored experiences, perceptions, and implementation challenges. Results: Analysis of FGDs yielded four major themes: (i) perceptions and acceptance of 3HP; (ii) barriers to 3HP; (iii) advocacy and communication and social mobilization; and (iv) suggestions for improving 3HP. Participants appreciated the short, once-weekly regimen and family encouragement supporting adherence. However, reluctance to undergo testing without symptoms, fear of side effects, stigma, and access barriers limited uptake. Suggested solutions included transport support, mobile X-ray services, reminder tools, and family DOTS providers. Providers highlighted workforce shortages and the need for additional staff. Conclusion: Both groups emphasized tailored counselling, strengthened community awareness, and media advocacy to improve uptake, adherence, and program sustainability of 3HP implementation at scale nationwide.
- Open Access
- 7 October 2024
- Published by Sechenov University in The BRICS Health Journal
- Vol. 1 (1) , 35-58
Current challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives
Tuberculosis (TB), the single most infectious killer deserves special attention in a focussed manner, to reduce morbidity and mortality. We describe the challenges in the four pillars of TB control: detect or diagnosis, treat, prevent, build and elaborate the success stories, listing out newer and advanced tools like artificial intelligence, whole genome sequencing, clustered regularly interspaced short palindromic repeats based technologies, one health approach and cost effectiveness strategies for an all- round reduction in TB control. Special problems posed by paediatric and extra-pulmonary TB are dealt with. Post TB lung sequalae, reverse zoonosis and behavioural modification that can influence catastrophic costs are explored. Use of molecular and genomic methods of TB detection has revolutionized TB care with increased sensitivity of diagnosis, and timely detection of drug resistance, saving many a precious lives. Undoubtedly, the need of the hour would be shortening TB treatment duration and comprehensive preventive strategies that simultaneously decrease both the incidence and prevalence of TB. The various schemes and initiatives undertaken by the Government of India including the Pradhan Mantri TB Mukt Bharat Abhiyaan – “TB free India” stand as a unique solution in the wake of eliminating TB. India has been extending its success stories to other countries as well, by creating platforms for multilateral research and multinational implementation. This manuscript gives a concise and comprehensive outlook of process involved in TB elimination, amalgamating the research evidences with the programmatic initiatives, enlisting the existing challenges, envisaging the current achievements, providing a road map for TB elimination.
- 7 October 2024
- Published by Sechenov University in The BRICS Health Journal
- Vol. 1 (1) , 35-58
Open AccessCurrent challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives
Tuberculosis (TB), the single most infectious killer deserves special attention in a focussed manner, to reduce morbidity and mortality. We describe the challenges in the four pillars of TB control: detect or diagnosis, treat, prevent, build and elaborate the success stories, listing out newer and advanced tools like artificial intelligence, whole genome sequencing, clustered regularly interspaced short palindromic repeats based technologies, one health approach and cost effectiveness strategies for an all- round reduction in TB control. Special problems posed by paediatric and extra-pulmonary TB are dealt with. Post TB lung sequalae, reverse zoonosis and behavioural modification that can influence catastrophic costs are explored. Use of molecular and genomic methods of TB detection has revolutionized TB care with increased sensitivity of diagnosis, and timely detection of drug resistance, saving many a precious lives. Undoubtedly, the need of the hour would be shortening TB treatment duration and comprehensive preventive strategies that simultaneously decrease both the incidence and prevalence of TB. The various schemes and initiatives undertaken by the Government of India including the Pradhan Mantri TB Mukt Bharat Abhiyaan – “TB free India” stand as a unique solution in the wake of eliminating TB. India has been extending its success stories to other countries as well, by creating platforms for multilateral research and multinational implementation. This manuscript gives a concise and comprehensive outlook of process involved in TB elimination, amalgamating the research evidences with the programmatic initiatives, enlisting the existing challenges, envisaging the current achievements, providing a road map for TB elimination.